Sincerity Pharmaceutical Industry: Docosahexaenoic Acid Ethyl Ester Soft Capsules obtained drug registration certificate.

Sincerity Pharmaceuticals announces that recently it has received the "Drug Registration Certificate" issued by the National Medical Products Administration for its product, icosapent ethyl soft capsules. This drug is used to lower the triglyceride levels in adults with severe hypertriglyceridemia on the basis of controlling diet. It is also used in combination with statins for the treatment of adults diagnosed with cardiovascular diseases or diabetes with 2 other cardiovascular risk factors, and who also have hypertriglyceridemia, in order to reduce the risk of cardiovascular events. The total research and development investment for the company's icosapent ethyl soft capsules amounts to 15.603 million yuan.